Neumora Therapeutics (NMRA) Tax Rate (2024 - 2026)

Neumora Therapeutics' Tax Rate history runs 3 years deep, the most recent figure standing at 0.06% for Q1 2026.

• On a quarterly basis, Tax Rate rose 10.0% year-over-year to 0.06% in Q1 2026; TTM through Mar 2026 was 0.0%, a 11.0% increase from a year earlier, with the FY2025 full-year figure at 0.03%, up 4.0% from the prior year.
• Tax Rate declined to 0.06% in Q1 2026 per NMRA's latest filing, from 0.08% in the prior quarter.
• Across five years, Tax Rate topped out at 0.08% in Q4 2025 and bottomed at 0.21% in Q2 2024.
• The 3-year median for Tax Rate is 0.06% (2026), against an average of 0.08%.
• Across the five-year window, Tax Rate gained 17 bps in 2025 and advanced 10 bps in 2026, its largest moves.
• Year by year, Tax Rate stood at 0.07% in 2024, then soared by 215 bps to 0.08% in 2025, then plunged by 167 bps to 0.06% in 2026.
• Per Business Quant, the three latest NMRA Tax Rate figures stand at 0.06% (Q1 2026), 0.08% (Q4 2025), and 0.05% (Q2 2025).